THIRD ROCK VENTURES V, L.P. sold 0.3% of their position (18.57K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $743.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/28/2026ACC: 0001193125-26-245259
10% Owner
Since Jun 2024
-18.57K
Net shares
Net seller
$743.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
18.57K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−18.57K
Price / share
$40.05
Trade value
$743.75K
% of position
0.3%
5/26/2026
6.30M→6.28M
Total
Net shares
−18.57K
Net value
-$743.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/26/2026 | S · Sale | −18.57K | $40.05 | $743.75K | 0.3% | 6.30M | 6.28M |
| Total | −18.57K | -$743.75K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned969.22K
Total
969.22K indirect969.22K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 969.22K | Indirect |
| Total | 969.22K | 969.22K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported